Detalles de la búsqueda
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35660812
2.
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma.
N Engl J Med
; 376(14): 1311-1320, 2017 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28379796
3.
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.
Haematologica
; 104(10): 1974-1983, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30948484
4.
Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide.
Br J Haematol
; 166(3): 401-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24761838
5.
Racial and Ethnic Composition of Populations Served by Freestanding Children's Hospitals and Disparities in Outcomes of Pediatric Lupus.
Arthritis Care Res (Hoboken)
; 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374576
6.
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome.
Nat Commun
; 12(1): 1334, 2021 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33637765
7.
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).
Br J Haematol
; 151(2): 143-51, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735398
8.
Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).
Leuk Lymphoma
; 58(8): 1814-1822, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27967294
9.
Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
Leuk Lymphoma
; 47(6): 998-1005, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16840188
10.
Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes.
Oral Oncol
; 49(9): 977-983, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23830962
11.
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
J Clin Oncol
; 31(33): 4199-206, 2013 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127452
12.
Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.
Clin Cancer Res
; 16(8): 2435-42, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20371683
13.
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
J Clin Oncol
; 24(19): 3121-7, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16754935
14.
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
Blood
; 107(11): 4207-13, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16449523
Resultados
1 -
14
de 14
1
Próxima >
>>